Back

Notification report


Full notification file


General information

Notification Number
B/NL/11/003

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
25/07/2011

Title of the Project
Administration of donor specific T-cells transduced ex vivo using a retroviral vector coding for a leukemia-specific TCR, as a cellular treatment after allogeneic stem cell transplantation for patients with refractory or relapsed hematological malignancies.

Proposed period of release:
01/03/2012 to 31/12/2017

Name of the Institute(s) or Company(ies)
Leiden University Medical Center, Albinusdreef 2
2333 ZA Leiden
PO Box 9600
2300 RC Leiden
The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Retrovirus, Moloney murine leukemia virus (Mo-MuLV)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Mo-MuLVGamma retrovirusMurine leukemia virusdl58rev mutant

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known